Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia
The DOI matches its Crossref record.
Abstract
Background and study aims Primary sclerosing cholangitis (PSC) is associated with increased risk of biliary dysplasia and cholangiocarcinoma (CCA). The aim of this study was to evaluate the role of early endoscopic retrograde cholangiography (ERC) with systematic brush cytology to identify risk factors associated with biliary neoplasia. Patients and methods Patients who were referred for their first ERC for suspicion of PSC between January 2006 and October 2011 were included in the study. Brush cytology specimens were scored as benign, suspicious, or malignant. End points were CCA, biliary dysplasia, benign histology, or benign disease course for ≥ 2 years. Results PSC was diagnosed in 261 patients (125 men, 136 women), most of whom were asymptomatic (n = 211). Cholangiographic changes were mild in 57.1 %. Men presented with advanced disease more often than women. Brush cytology was benign in 243, suspicious in 16, and malignant in 2 patients. Follow-up completed in 249 patients indicated a benign disease course in 232 patients. Seven patients were diagnosed with CCA and eight had biliary dysplasia in the explanted liver. Thus, 15 patients had biliary neoplasia, and suspicious or malignant brush cytology had been detected in 8 of them at initial brushing. Advanced extrahepatic cholangiographic changes with elevated aminotransferases at diagnosis seemed to be associated with increased risk of biliary neoplasia. Conclusions Even in mostly asymptomatic patients with PSC, 42.9 %…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“data from Finland suggest that ERCP, especially in advanced extrahepatic PSC, may be beneficial for detection of premalignant or malignant lesions regardless of symptoms.131”
From EASL Clinical Practice Guidelines on sclerosing cholangitis (2022) · cites this paper as [131]
Citations
Cited by
EASL Clinical Practice Guidelines on sclerosing cholangitis
Chazouilleres, O., Beuers, U., Bergquist, A., Karlsen, T. H., Levy, C., Samyn, M., Schramm, C., & Trauner, M. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.05.011 · Cited by 419
Chapman, M. H., Thorburn, D., Hirschfield, G. M., Webster, G. G. J., Rushbrook, S. M., Alexander, G., Collier, J., Dyson, J. K., Jones, D. E., Patanwala, I., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-317993 · Cited by 284
Aabakken, L., Karlsen, T., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G., Laghi, A., et al. (2017) · Endoscopy · doi:10.1055/s-0043-107029 · Cited by 255
Self-citationSchramm, C., Eaton, J., Ringe, K. I., Venkatesh, S., Yamamura, J., & for the MRI working group of the IPSCSG (2017) · Hepatology · doi:10.1002/hep.29293 · Cited by 147
“The development of such features should prompt additional studies including ERCP with biliary brushings/biopsies.((78-80)) There is neither supporting nor refuting evidence to suggest that CCA screening with any test is associated with improved outcomes or cost-savings.”
BackgroundAabakken, L., Karlsen, T. H., Albert, J., Arvanitakis, M., Chazouilleres, O., Dumonceau, J.-M., Färkkilä, M., Fickert, P., Hirschfield, G. M., Laghi, A., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.013 · Cited by 107
“A complete occlusion cholangiogram should generally be obtained if an ERCP is performed, because it adds little risk to the ERCP, decreases variability, and may reveal that a dominant stricture suspected at MRC is indeed not a stricture [37].”
Self-citation
Metadata
- Authors
- Boyd, S., Tenca, A., Jokelainen, K., Mustonen, H., Krogerus, L., Arola, J., & Färkkilä, M.
- Affiliations
- University of Helsinki (FI)
- Venue
- Endoscopy
- Publisher
- Georg Thieme Verlag KG
- Published
- 2016-01-25
- Volume
- 48
- Issue
- 05
- Pages
- 432-439
- ISSN
- 0013-726X (ISSN-L)
- 1438-8812
- OpenAlex
- W2290113997
- Cited by
- 50
- References
- 0
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 3 · 2017: 9 · 2016: 3
- FWCI
- 4.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endoscopy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
- Keywords
- primary sclerosing cholangitis, biliary dysplasia, cholangiocarcinoma, brush cytology, endoscopic retrograde cholangiography, transaminases, early detection, asymptomatic patients
- MeSH terms
- Adult, Transaminases, Bile Duct Neoplasms, Bile Ducts, Cholangiopancreatography, Endoscopic Retrograde, Cytodiagnosis, Diagnosis, Differential, Female, Finland, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, Cholangitis, Sclerosing, Cholangiocarcinoma, Early Detection of Cancer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia. https://app.cochat.ai/papers/10.1055/s-0041-110792
- The paper
- Boyd, S., Tenca, A., Jokelainen, K., Mustonen, H., Krogerus, L., Arola, J., & Färkkilä, M. (2016). Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia. Endoscopy. https://doi.org/10.1055/s-0041-110792
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.